Abstract:Antimicrobial peptides (AMPs) are naturally produced by pro- and eukaryotes and are promising alternatives to antibiotics to fight multidrug-resistant microorganisms. However, despite thousands of AMP entries in respective databases, predictions about their structure–activity relationships are still limited. Similarly, common or dissimilar properties of AMPs that have evolved in different taxonomic groups are nearly unknown. We leveraged data entries for 10,987 peptides currently listed in the three antimicrobial peptide databases APD, DRAMP and DBAASP to aid structure–activity predictions. However, this number reduced to 3,828 AMPs that we could use for computational analyses, due to our stringent quality control criteria. The analysis uncovered a strong bias towards AMPs isolated from amphibians (1,391), whereas only 35 AMPs originate from fungi (0.9%), hindering evolutionary analyses on the origin and phylogenetic relationship of AMPs. The majority (62%) of the 3,828 AMPs consists of less than 40 amino acids but with a molecular weight higher than 2.5 kDa, has a net positive charge and shares a hydrophobic character. They are enriched in glycine, lysine and cysteine but are depleted in glutamate, aspartate and methionine when compared with a peptide set of the same size randomly selected from the UniProt database. The AMPs that deviate from this pattern (38%) can be found in different taxonomic groups, in particular in Gram-negative bacteria. Remarkably, the γ-core motif claimed so far as a unifying structural signature in cysteine-stabilised AMPs is absent in nearly 90% of the peptides, questioning its relevance as a prerequisite for antimicrobial activity. The disclosure of AMPs pattern and their variation in producing organism groups extends our knowledge of the structural diversity of AMPs and will assist future peptide screens in unexplored microorganisms. Structural design of peptide antibiotic drugs will benefit using natural AMPs as lead compounds. However, a reliable and statistically balanced database is missing which leads to a large knowledge gap in the AMP field. Thus, thorough evaluation of the available data, mitigation of biases and standardised experimental setups need to be implemented to leverage the full potential of AMPs for drug development programmes in the clinics and agriculture.

Antimicrobial Peptides as Broad-Spectrum Therapeutics: Computational Analysis to Identify Universal Physical-Chemical Features Responsible for Multitarget Activity

High Throughput Meta-analysis of Antimicrobial Peptides for Characterizing Class Specific Therapeutic Candidates: An Approach

Antimicrobial peptides designed by computational analysis of proteomes

Computational resources and tools for antimicrobial peptides

Structure–Activity Predictions From Computational Mining of Protein Databases to Assist Modular Design of Antimicrobial Peptides

A novel bioinformatic method for the identification of antimicrobial peptides in metagenomes

Distinct Profiling of Antimicrobial Peptide Families.

Little Antimicrobial Peptides with Big Therapeutic Roles

Computational Methods and Tools in Antimicrobial Peptide Research

Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Physicochemical Features and Peculiarities of Interaction of Antimicrobial Peptides with the Membrane

HMAMP: Hypervolume-Driven Multi-Objective Antimicrobial Peptides Design

Insight into the Structural Requirements of Antimicrobial Peptides by Multiple Validated 3D-QSAR Approaches

Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides

Differences in Relevant Physicochemical Properties Correlate with Synergistic Activity of Antimicrobial Peptides

Discovery of AMPs from random peptides via deep learning-based model and biological activity validation

An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining

Exploring the repository of designed bifunctional antimicrobial peptides through deep learning

Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities

The Antimicrobial Peptides and Their Potential Clinical Applications.